Judit Józwiak‐Hagymásy

Understanding the stakeholders’ intention to use economic decision-support tools: A cross-sectional study with the tobacco return on investment tool

Kei Long Cheung, Silvia Evers, Mickaël Hiligsmann et al. · Health Policy · 2015 · 28 citations · Full text

Public Health, Health Promotion, Behavior Change Theory +14

Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder

Antal Zemplényi, Judit Józwiak‐Hagymásy, Sándor Kovács et al. · BMC Psychiatry · 2022 · 23 citations · Full text

Pharmacy, Pharmacoeconomics, Psychiatry +17

Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey

Zoltán Vokó, Kei Long Cheung, Judit Józwiak‐Hagymásy et al. · Health Research Policy and Systems · 2016 · 21 citations · Full text

Public Affairs, Health Policy, Health Economics +16

A health systems approach to identifying barriers to breast cancer screening programmes. Methodology and application in six European countries

Eleanor Turnbull, Jennifer Priaulx, Nicolien T. van Ravesteyn et al. · Health Policy · 2018 · 16 citations · Full text

Medicine, Health Policy, Health Systems +14

The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids

Balázs Nagy, György Timár, Judit Józwiak‐Hagymásy et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2014 · 14 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +8